𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potential Role of KRAS and Other Mutations in the Adjuvant Therapy of Colorectal Cancer

✍ Scribed by Gilles Manceau, Pierre Laurent-Puig


Book ID
118819454
Publisher
Current Science Inc.
Year
2012
Tongue
English
Weight
216 KB
Volume
8
Category
Article
ISSN
1556-3790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Frequency of KRAS, BRAF, and NRAS mutati
✍ Cecily P. Vaughn; Scott D. ZoBell; Larissa V. Furtado; Christine L. Baker; Wade πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract Mutational analysis of __KRAS__ codons 12 and 13 is standard for patients with metastatic colorectal cancer since mutations in these codons predict lack of response to anti‐EGFR therapies. However, even among patients whose tumors are wildtype for __KRAS__ codons 12 and 13, only a subse

The role of chemotherapy and adjuvant th
✍ Walter B. Forman πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 256 KB πŸ‘ 3 views

This review of the current literature related to the use of chemo-and adjuvant chemotherapy in colorectal carcinoma emphasizes the present dilemma in caring for people affected with this disorder. Adjuvant chemotherapy using combinations of 5-fluorouracil and levamisole clearly prolong survival, alb